{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Davie",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "72308",
      "recalling_firm": "Actavis Laboratories, FL, Inc.",
      "address_1": "4955 Orange Dr",
      "address_2": "N/A",
      "postal_code": "33314-3902",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "recall_number": "D-0014-2016",
      "product_description": "Metformin Hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL  33314 USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ  07054 USA; NDC 0591-2720-60; UPC 3 05912 72060 3.",
      "product_quantity": "13,284 bottles",
      "reason_for_recall": "Failed Dissolution Specifications: Low Out-of-Specification results for the 8 hour timepoint.",
      "recall_initiation_date": "20150925",
      "center_classification_date": "20151013",
      "termination_date": "20170410",
      "report_date": "20151021",
      "code_info": "Lot: 1037736A, Exp 03/18"
    }
  ]
}